WP 1874
Alternative Names: WP-1244; WP-1874; WP1244/WP1874Latest Information Update: 28 Feb 2024
At a glance
- Originator University of Texas M. D. Anderson Cancer Center
- Developer CNS Pharmaceuticals
- Class Anthracyclines; Antineoplastics; Distamycins; Mesylates; Small molecules
- Mechanism of Action Cell proliferation inhibitors; DNA intercalators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Lymphoma; Ovarian cancer; Pancreatic cancer
- No development reported Brain cancer